Scientists are on a mission to resurrect the woolly mammoth by 2028, using cutting-edge genetic engineering and cloning ...

Colossal Biosciences cofounder and CEO Ben Lamm is worth $3.7 billion following the company's recent fundraise at an ...

The non-descript, pill-shaped cell is why we understand fundamental life processes (think DNA replication and transcription).

A gene called high mobility group A1 (HMGA1) may be the key that opens the door to the development of colon cancer, according ...

Recent innovations in DNA-modifying will revolutionize the treatment of many diseases and prompt crucial discussions.

Breakthrough in artificial intelligence offers unprecedented insights into DNA sequencing and genetic engineering.

A new study from Western New England University (WNE) has revealed that long-term grape consumption significantly impacts muscle health, with ...

California-based nonprofit Arc Institute and Stanford University, in collaboration with NVIDIA, unveiled Evo 2 on Wednesday ...

A gene called high mobility group A1 (HMGA1) may be the key that opens the door to the development of colon cancer, according ...

Beijing’s surprise move to blacklist Illumina Inc. has unleashed a frenzy among the US firm’s Chinese rivals to win market share from the gene-sequencing giant.

The evolution of cell and gene therapy is reshaping drug discovery, providing new hope for rare diseases and cancer through innovative gene editing approaches.

Researchers say if their results are confirmed through further study they are optimistic the approach could be used to treat ...